← Open Payments lookup

MICHAEL RISTAGNO: Open Payments

NPI 1689324824 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$975 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $452 · 2025 $975

Food & beverage: $975
CompanyPaymentsAmount
ABBVIE INC.34$598
Otsuka America Pharmaceutical, Inc.6$110
Janssen Pharmaceuticals, Inc4$72
Lundbeck LLC3$45
Axsome Therapeutics, Inc.2$45
Supernus Pharmaceuticals, Inc.1$33
Teva Pharmaceuticals USA, Inc.2$28
Vanda Pharmaceuticals Inc.1$22
Neurocrine BioSciences, Inc.1$21

Products named: VRAYLAR, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, Auvelity, ABILIFY MAINTENA, Qelbree, FANAPT.

Industry payments across TX — which companies pay providers there.